Rigel Pharmaceuticals, Inc. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Rigel Pharmaceuticals with three other
companies in this sector in the United States:
sales of $19.36 million
of which 100%
Imprimis Pharmaceuticals Incorporated
ProPhase Labs Inc
Rigel Pharmaceuticals reported sales of $20.38 million
December of 2016.
decrease of 29.5%
versus 2015, when the company's sales were $28.90 million.